$1.00
+0.03 (+2.64%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,694.0% upside
Low Target
$25.58
Average Target
$37.94
High Target
$45.71
Current Price
$1.00
Current
$1.00
$1.00
Target
$37.94
$37.94
$25.58
$37.94 avg
$45.71
Scenario Analysis
Bear Case
$25.58
2,458.0%
Low target
Base Case
$37.94
+3,694.0%
Avg target
Bull Case
$45.71
+4,471.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.35
-57.4% from high
52-Week Low
$0.87
+15.4% from low
Target vs 52W High
$37.94
+1,514.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |